Navigation Links
Dr. Mark F. Rindge Launches Ground-Breaking Cavity Prevention Program That Can Lower Decay Rates by 74%
Date:2/4/2013

Los Gatos, Calif. (PRWEB) February 04, 2013

Dental decay is the number 1 chronic disease affecting American youth, surpassing both obesity and asthma.

For Dr. Mark F. Rindge of Los Gatos, Calif., and his team, those statistics are no longer daunting. They have taken the top caries research in the world and implemented a cavity prevention program developed by CariFree that is shown to decrease incidents of tooth decay by up to 74%. The system is known as CAMBRA or Caries Management by Risk Assessment.

“Never before have we had a tool to indicate that decay is imminent. We are excited to be able to prevent decay before it becomes a serious problem,” states Dr. Rindge.

CAMBRA is rooted in a medical model of risk assessment. It requires the dental professional to assess each and every patient’s risk factors for the disease and then develop a personalized treatment plan to systematically lower their risk. The CariFree diagnostic tools leverage biofilm testing (to determine the levels of cavity-causing bacteria in the patient’s mouth) as well as a risk assessment questionnaire to determine the overall statistical probability a patient will develop new cavities over the next 12 months. Never before has such predictive information been available. Patients can then measurably lower their risk for decay by utilizing professional products and behavior modification.

Patients can expect the entire process to take a few minutes in their appointment. They will answer targeted questions regarding their current habits (eating and drinking, medication use, chronic health issues etc.) as well as undergo a quick, painless swab of their lower teeth (to determine if they have an excess of cavity causing bacteria). Dr. Rindge says the experience is positive as: “Patients are happy to get their results in as little as 20 seconds!”

Based on the information gathered, the dental team will counsel them on an appropriate course of action to lower their risk. If professional products are recommended the practitioner will provide the patient with a professional kit of product specifically designed to counteract their risk factors.

The CariFree products contain all 5 essential therapeutic agents proven to treat dental caries. Depending on the patients diagnosis the proper level of therapy will be prescribed. Science has proven that this disease cannot be stopped by the drill and fill approach. True cure requires a medical approach and a comprehensive assessment of each patient. Dr. Mark F. Rindge and his team have taken a bold and caring step for their patients and their community.

For more information on the CariFree system go to http://www.carifree.com. To make your caries risk appointment with Dr. Mark F. Rindge and his team call at 408-356-5300.

Read the full story at http://www.prweb.com/releases/2013/2/prweb10384694.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Amarantus BioScience Launches New Website
2. Touch Medical Media Splits From Touch Briefings, Launches a Series of Cutting Edge, Free to Access, Educational Resources and Signs an Updated Media Partnership With ECCO, The European CanCer Organisation Representing 60,000 Oncology Professionals
3. New York Microscope Launches New Website http://www.NYscopes.com
4. MDA Launches Clinical Network to Speed Myotonic Dystrophy Research
5. DuPont Pioneer Launches Next Generation T Series Soybeans
6. MedZilla.com Launches New Site Design for 2013, Slick New Interface Impresses
7. New EMR Comparison Website Launches Crowdsourcing Electronic Medical Record Software Reviews and Comparisons
8. ActiGraph Launches ActiLife Mobile App
9. Rockingham County Economic Development Launches New Website to Market Research and Tech Park
10. Scout Girl, LLC Launches Website Featuring Vermicomposting Supplies
11. Wysebridge Launches Patent Bar Exam Study Review
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... , Feb. 10, 2016  Allergan plc (NYSE: ... announced that Brent Saunders , Allergan,s CEO and ... a fireside chat session at the RBC Capital Markets ... p.m. ET at The New York Palace Hotel in ... will be webcast live and can be accessed on ...
(Date:2/10/2016)... ... 10, 2016 , ... LATHAM, NEW YORK... Marktech Optoelectronics will feature ... in San Francisco’s Moscone Center from February 16-18, 2016, and at the healthcare-focused ... latest InGaAs PIN diode standard packages feature a TO-46 metal can with active areas ...
(Date:2/10/2016)... , ... February 10, 2016 , ... ... medicine, has announced a new agreement with Singapore-based Global Stem Cells Network (GSCN) ... the Philippines, Thailand and Singapore in the latest adipose and bone marrow therapies. ...
(Date:2/9/2016)... 9, 2016  Regenicin, Inc. (OTC Bulletin Board: ... the development and commercialization of regenerative cell therapies ... organs, recently reported the Company,s operating results for ... 2016. Lonza America , Inc. (the ... year in the process of consummating an agreement ...
Breaking Biology Technology:
(Date:2/2/2016)... , Feb. 2, 2016 This BCC ... bioinformatic market by reviewing the recent advances in ... that drive the field forward. Includes forecast through ... Identify the challenges and opportunities that exist in ... software solution developers, as well as IT and ...
(Date:2/2/2016)... , Feb. 2, 2016  Based on its ... & Sullivan recognizes US-based Intelligent Retinal Imaging Systems ... Sullivan Award for New Product Innovation. IRIS, a ... North America , is poised to ... growing diabetic retinopathy market. The IRIS technology presents ...
(Date:1/28/2016)... SAN JOSE, Calif., Jan. 28, 2016 Synaptics (NASDAQ: ... financial results for its second quarter ended December 31, 2015. ... the second quarter of fiscal 2016 increased 2 percent compared to ... the second quarter of fiscal 2016 was $35.0 million, or $0.93 ... Non-GAAP net income for the first quarter of fiscal 2016 ...
Breaking Biology News(10 mins):